James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 7,244 shares at $57.08 ($421K) on 2019-05-08, disclosed to the SEC on 2019-05-10.
Open-market sale of $421k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.08 | 600 | $34K | 8.1% |
| 2 | $57.15 | 358 | $20K | 4.9% |
| 3 | $57.15 | 700 | $40K | 9.5% |
| 4 | $57.73 | 542 | $31K | 7.4% |
| 5 | $57.82 | 1,044 | $60K | 14.3% |
| 6 | $57.89 | 1,258 |
| $73K |
| 17.3% |
| 7 | $58.86 | 600 | $35K | 8.4% |
| 8 | $58.91 | 1,142 | $67K | 16.0% |
| 9 | $58.94 | 1,000 | $59K | 14.0% |
| Total | $58.08 avg | 7,244 | $421K | 100% |
| Filing → |
| GHDX | SELL | 2019-06-10 | $459K | — | Filing → |
| GHDX | SELL | 2018-10-10 | $3.2M | — | Filing → |
| GHDX | SELL | 2018-06-06 | $4.3M | — | Filing → |